Clinical trial
Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With…
NCT00406536 · Avanti Polar Lipids, Inc., Industry · Completed
Key facts
| NCT number | NCT00406536 |
|---|---|
| Title | Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI |
| Official title | Phase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CF |
| Lead sponsor | Avanti Polar Lipids, Inc., Industry |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Pancreatic Insufficiency |
| Intervention type | Dietary Supplement |
| Interventions | Lym-X-Sorb powder, Placebo powder |
| Enrollment | 110 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Dec 4, 2006 |
| Last update posted | Jan 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: